Skip to main content
Kent Academic Repository

Items where Author, Editor or other role is "Schlichtner, Stephanie"

Group by: Creator's name | Item Type | Date | No Grouping
Jump to: A | S | T
Number of items: 4.

A

Abooali, Maryam, Yasinska, Inna M., Schlichtner, Stephanie, Ruggiero, Sabrina, Berger, Steffen M, Cholewa, Dietmar, Milošević, Milan, Bartenstein, Andreas, Fasler-Kan, Elizaveta, Sumbayev, Vadim V. and others. (2023) Activation of immune evasion machinery is a part of the process of malignant transformation of human cells. Translational oncology, 39 . Article Number 101805. ISSN 1936-5233. (doi:10.1016/j.tranon.2023.101805) (KAR id:103490)
Format: PDF

S

Schlichtner, Stephanie, Yasinska, Inna M., Lall, Gurprit S., Berger, Steffen M., Ruggiero, Sabrina, Cholewa, Dietmar, Aliu, Nijas, Gibbs, Bernhard F., Fasler-Kan, Elizaveta, Sumbayev, Vadim V. and others. (2023) T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins. Journal for ImmunoTherapy of Cancer, 11 (1). Article Number e005714. E-ISSN 2051-1426. (doi:10.1136/jitc-2022-005714) (KAR id:99577)
Format: PDF

Schlichtner, Stephanie (2022) Fundamental immunosuppressive pathway determining ability of cancer and embryonic cells to escape cytotoxic immune attack. Doctor of Philosophy (PhD) thesis, University of Kent,. (doi:10.22024/UniKent/01.02.99185) (KAR id:99185)
Format: PDF

T

Teo Hansen Selnø, Anette, Schlichtner, Stephanie, Yasinska, Inna M., Sakhnevych, Svetlana S., Fiedler, Walter, Wellbrock, Jasmin, Berger, Steffen M., Klenova, Elena, Gibbs, Bernhard F, Fasler-Kan, Elizaveta, and others. (2021) High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells. Frontiers in Immunology, 12 . Article Number 675731. E-ISSN 1664-3224. (doi:10.3389/fimmu.2021.675731) (KAR id:90457)
Format: PDF

This list was generated on Wed Apr 17 19:27:00 2024 BST.